share_log

UnitedHealth | 10-Q: Q2 2024 Earnings Report

UnitedHealth | 10-Q: Q2 2024 Earnings Report

聯合健康 | 10-Q:2024財年二季報
美股SEC公告 ·  08/10 04:15

Moomoo AI 已提取核心訊息

UnitedHealth Group, comprising UnitedHealthcare and Optum, reported a 6% increase in consolidated revenues to $98.855 billion for the second quarter of 2024 compared to the same period in 2023. The revenue growth was primarily driven by Optum Rx and Optum Health, with UnitedHealthcare revenues growing by 5%. Earnings from operations for the quarter were $7.875 billion, a slight decrease from $8.057 billion in the previous year, largely due to the impact of the Change Healthcare cyberattack. The diluted earnings per share stood at $4.54, influenced by the cyberattack and the loss on South American subsidiaries held for sale. The company's medical care ratio increased slightly to 85.1%, and the operating cost ratio improved by 1.6%. UnitedHealthcare experienced growth in Medicare Advantage and domestic commercial offerings, while Optum Health and...Show More
UnitedHealth Group, comprising UnitedHealthcare and Optum, reported a 6% increase in consolidated revenues to $98.855 billion for the second quarter of 2024 compared to the same period in 2023. The revenue growth was primarily driven by Optum Rx and Optum Health, with UnitedHealthcare revenues growing by 5%. Earnings from operations for the quarter were $7.875 billion, a slight decrease from $8.057 billion in the previous year, largely due to the impact of the Change Healthcare cyberattack. The diluted earnings per share stood at $4.54, influenced by the cyberattack and the loss on South American subsidiaries held for sale. The company's medical care ratio increased slightly to 85.1%, and the operating cost ratio improved by 1.6%. UnitedHealthcare experienced growth in Medicare Advantage and domestic commercial offerings, while Optum Health and Optum Rx saw increases in revenues and earnings from operations. The company also highlighted the substantial progress in mitigating the impact of the Change Healthcare cyberattack, including restoring most services and providing over $9 billion in funding and interest-free loans to support care providers. Looking ahead, UnitedHealth Group expects to continue incurring costs related to the cyberattack and is focused on managing medical cost trends and pricing strategies to balance growth and profitability.
聯合健康集團,包括聯合醫療保健和Optum,在2024年第二季度的營業收入中報告了6%的增長,達到了988.55億美元,而在2023年同期的營業收入爲—988.55億美元。收入增長主要由Optum Rx和Optum Health推動,聯合醫療保健的營收增長5%。本季度運營收入爲78.75億美元,與上年的80.57億美元相比略有下降,主要是由於Change Healthcare網絡攻擊的影響。每股攤薄收益爲4.54美元,受網絡攻擊和南美子公司售虧損的影響。公司的醫療保健比率略有增加,達到了85.1%,運營成本比率提高了1.6%。聯合醫療保健在醫療保險優勢和國內商業方面都有增長,而Optum He...展開全部
聯合健康集團,包括聯合醫療保健和Optum,在2024年第二季度的營業收入中報告了6%的增長,達到了988.55億美元,而在2023年同期的營業收入爲—988.55億美元。收入增長主要由Optum Rx和Optum Health推動,聯合醫療保健的營收增長5%。本季度運營收入爲78.75億美元,與上年的80.57億美元相比略有下降,主要是由於Change Healthcare網絡攻擊的影響。每股攤薄收益爲4.54美元,受網絡攻擊和南美子公司售虧損的影響。公司的醫療保健比率略有增加,達到了85.1%,運營成本比率提高了1.6%。聯合醫療保健在醫療保險優勢和國內商業方面都有增長,而Optum Health和Optum Rx在營收和運營收益方面都有所增長。公司還強調了緩解Change Healthcare網絡攻擊影響的實質性進展,包括恢復大多數服務,提供超過90億美元的資金和無息貸款,爲支持醫療保健供應商提供支持。展望未來,聯合健康集團預計將繼續承擔與網絡攻擊相關的成本,並專注於管理醫療成本趨勢和定價策略,以平衡增長和盈利能力。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息